EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.

Li Y, Wilson A, Chrisochoidou Y, Martin S, Bird S, Morales S, Leiro M, Kozik Z, Crump NT, Roumeliotis TI, Choudhary J, Pawlyn C

Open source

DOI
10.3324/haematol.2025.288024
Published
2026 Aug 1
Container
Haematologica
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2025.288024,
  title = {EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.},
  author = {Li Y and Wilson A and Chrisochoidou Y and Martin S and Bird S and Morales S and Leiro M and Kozik Z and Crump NT and Roumeliotis TI and Choudhary J and Pawlyn C},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2025.288024},
  url = {https://doi.org/10.3324/haematol.2025.288024}
}

RIS

TY  - JOUR
TI  - EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.
AU  - Li Y
AU  - Wilson A
AU  - Chrisochoidou Y
AU  - Martin S
AU  - Bird S
AU  - Morales S
AU  - Leiro M
AU  - Kozik Z
AU  - Crump NT
AU  - Roumeliotis TI
AU  - Choudhary J
AU  - Pawlyn C
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2025.288024
UR  - https://doi.org/10.3324/haematol.2025.288024
ER  - 

APA

Y, L., A, W., Y, C., S, M., S, B., S, M., M, L., Z, K., NT, C., TI, R., J, C., & C, P. (2026). EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway.. Haematologica. https://doi.org/10.3324/haematol.2025.288024

Source records